ArticleMicrosystems & nanoengineering2026
Microfluidic encapsulation of the human gut microbiota-a tool for research and beyond.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Over the past few decades, the importance of the human gut microbiota has been cast into the limelight. A growing number of studies are attempting to detangle the complex functions of the gut microbiota for human health; however, one existing shortcoming is an incomplete understanding of the microbiota community composition. Up to 70% of bacteria colonizing the human gastrointestinal tract are estimated to lack complete genomic or functional characterization due to their low abundance within the gastrointestinal tract or challenge to culture. As traditional culture methods often favour fast-growing or easily cultured species, alternative strategies are needed to access the broader gut microbial diversity. Here, we propose a novel approach to improve the growth of difficult-to-culture gut bacteria through single-cell microencapsulation, which will allow for in vitro manipulation. This work provides evidence of high biocompatibility of four-arm poly(ethylene glycol) maleimide (PEG4MAL) for gastrointestinal microbial culture and significant anaerobic gut bacteria proliferation in PEG4MAL microbeads generated via microfluidics. Specifically, we varied the concentration of PEG4MAL and the presence of Arg-Gly-Asp peptide motifs to tune the mechanical properties and porosity of the microbeads, and examined their impact on bacterial viability, confluency, and colony formation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.